A Phase I/II Clinical Trial for HS_SW01 Cells Injection in the Treatment of Primary Ovarian Insufficiency
Latest Information Update: 05 May 2026
At a glance
- Drugs HS SW 01 (Primary)
- Indications Primary ovarian insufficiency
- Focus Adverse reactions
- Acronyms HS_SW01
- Sponsors Shenzhen Huishan Biotechnology
Most Recent Events
- 05 May 2026 New trial record